Related Experiment Video
Updated: Nov 24, 2025
11:13
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
1.9K
Targeting the Mevalonate Pathway in Cancer
Dennis Juarez1, David A Fruman1
1Department of Molecular Biology and Biochemistry, University of California, Irvine, CA 92697, USA.
Trends in Cancer
|December 28, 2020
Summary
Statins, used for cholesterol management, also impact cancer development by affecting protein geranylgeranylation. Understanding this pathway is key to improving statin therapy in oncology.
Area of Science:
- Biochemistry
- Oncology
- Pharmacology
Background:
- Statins are primary drugs for cholesterol management and cardiovascular health.
- The mevalonate pathway, targeted by statins, supports oncogenesis, including macropinocytosis.
- Statin sensitivity is linked to dependence on protein geranylgeranylation, a mevalonate pathway output.
Purpose of the Study:
- To explore the role of the mevalonate pathway and protein geranylgeranylation in cancer.
- To investigate novel tools for understanding statin mechanisms.
- To inform clinical application of statins in oncology.
Main Methods:
- Utilized new chemical prenylation probes.
- Identified a novel geranylgeranyl transferase.
- Analyzed statin selection and dietary geranylgeraniol effects.
Main Results:
- Protein geranylgeranylation is a key factor in statin sensitivity and cancer cell processes.
- Novel probes and enzymes offer new avenues for studying statin action.
- Dietary geranylgeraniol may counteract therapeutic benefits of statins.
Conclusions:
- Understanding protein geranylgeranylation is crucial for optimizing statin therapy in cancer.
- Statins have potential as an oncology treatment when used strategically.
- Further research into statin mechanisms and clinical application is warranted.
Related Concept Videos
02:57Targeted Cancer Therapies
8.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.1K
02:50Combination Therapies and Personalized Medicine
5.6K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.6K
01:46Electron Transport Chain: Complex I and II
17.2K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
17.2K
03:03mTOR Signaling and Cancer Progression
4.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.1K
02:49Cancer Therapies
9.1K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.1K
02:34Inhibition of Cdk Activity
5.3K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.3K